Gastric Dysplasia
17
5
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
18%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (17)
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Narrow Band Imaging for Gastric Neoplasia
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
Endoscopic Closure of Gastric ESD Defect
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer
Novel Approach to Surveillance of Gastric Lesions
Magnifying Endoscopy With Narrow Band Imaging Versus Endoscopic Ultrasonography for Prediction of Tumor Invasion Depth in Early Gastric Cancer: A Prospective Comparative Study
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
Surveillance of Patients With Precancerous Lesions of the Stomach
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
Endoscopic Submucosal Dissection Using a Thulium Laser
Radiofrequency Ablation for Gastric Metaplasia and Dysplasia
Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
Conventional Biopsies vs pCLE for Diagnosis of Superficial Gastric Neoplasia